Literature DB >> 23252690

Donor selection and release criteria of cellular therapy products.

H Eichler, H Schrezenmeier, K Schallmoser, D Strunk, J Nystedt, T Kaartinen, M Korhonen, S Fleury-Cappellesso, L Sensebé, H Bönig, P Rebulla, R Giordano, L Lecchi, M Takanashi, S M Watt, E B Austin, M Guttridge, L S McLaughlin, S Panzer, H W Reesink.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23252690     DOI： 10.1111/j.1423-0410.2012.01619.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN： 0042-9007            Impact factor:   2.144


× No keyword cloud information.
  6 in total

1.  Standard requirement of a microbiological quality control program for the manufacture of human mesenchymal stem cells for clinical use.

Authors:  Patricia Gálvez; Beatriz Clares; Maria Bermejo; Abdelkrim Hmadcha; Bernat Soria
Journal:  Stem Cells Dev       Date:  2014-02-20       Impact factor: 3.272

2.  Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper.

Authors:  Thomas Lener; Mario Gimona; Ludwig Aigner; Verena Börger; Edit Buzas; Giovanni Camussi; Nathalie Chaput; Devasis Chatterjee; Felipe A Court; Hernando A Del Portillo; Lorraine O'Driscoll; Stefano Fais; Juan M Falcon-Perez; Ursula Felderhoff-Mueser; Lorenzo Fraile; Yong Song Gho; André Görgens; Ramesh C Gupta; An Hendrix; Dirk M Hermann; Andrew F Hill; Fred Hochberg; Peter A Horn; Dominique de Kleijn; Lambros Kordelas; Boris W Kramer; Eva-Maria Krämer-Albers; Sandra Laner-Plamberger; Saara Laitinen; Tommaso Leonardi; Magdalena J Lorenowicz; Sai Kiang Lim; Jan Lötvall; Casey A Maguire; Antonio Marcilla; Irina Nazarenko; Takahiro Ochiya; Tushar Patel; Shona Pedersen; Gabriella Pocsfalvi; Stefano Pluchino; Peter Quesenberry; Ilona G Reischl; Francisco J Rivera; Ralf Sanzenbacher; Katharina Schallmoser; Ineke Slaper-Cortenbach; Dirk Strunk; Torsten Tonn; Pieter Vader; Bas W M van Balkom; Marca Wauben; Samir El Andaloussi; Clotilde Théry; Eva Rohde; Bernd Giebel
Journal:  J Extracell Vesicles       Date:  2015-12-31

3.  Immunomonitoring of MSC-Treated GvHD Patients Reveals Only Moderate Potential for Response Prediction but Indicates Treatment Safety.

Authors:  Joni Keto; Tanja Kaartinen; Urpu Salmenniemi; Johanna Castrén; Jukka Partanen; Arno Hänninen; Matti Korhonen; Kaarina Lähteenmäki; Maija Itälä-Remes; Johanna Nystedt
Journal:  Mol Ther Methods Clin Dev       Date:  2018-02-08       Impact factor: 6.698

4.  Children and Adults with Refractory Acute Graft-versus-Host Disease Respond to Treatment with the Mesenchymal Stromal Cell Preparation "MSC-FFM"-Outcome Report of 92 Patients.

Authors:  Halvard Bonig; Zyrafete Kuçi; Selim Kuçi; Shahrzad Bakhtiar; Oliver Basu; Gesine Bug; Mike Dennis; Johann Greil; Aniko Barta; Krisztián M Kállay; Peter Lang; Giovanna Lucchini; Raj Pol; Ansgar Schulz; Karl-Walter Sykora; Irene Teichert von Luettichau; Grit Herter-Sprie; Mohammad Ashab Uddin; Phil Jenkin; Abdulrahman Alsultan; Jochen Buechner; Jerry Stein; Agnes Kelemen; Andrea Jarisch; Jan Soerensen; Emilia Salzmann-Manrique; Martin Hutter; Richard Schäfer; Erhard Seifried; Shankara Paneesha; Igor Novitzky-Basso; Aharon Gefen; Neta Nevo; Gernot Beutel; Paul-Gerhardt Schlegel; Thomas Klingebiel; Peter Bader
Journal:  Cells       Date:  2019-12-05       Impact factor: 6.600

Review 5.  Human limbal epithelial stem cell regulation, bioengineering and function.

Authors:  Clémence Bonnet; Sheyla González; JoAnn S Roberts; Sarah Y T Robertson; Maxime Ruiz; Jie Zheng; Sophie X Deng
Journal:  Prog Retin Eye Res       Date:  2021-03-04       Impact factor: 21.198

6.  Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM).

Authors:  Peter Bader; Zyrafete Kuçi; Shahrzad Bakhtiar; Oliver Basu; Gesine Bug; Michael Dennis; Johann Greil; Aniko Barta; Krisztián M Kállay; Peter Lang; Giovanna Lucchini; Raj Pol; Ansgar Schulz; Karl-Walter Sykora; Irene von Luettichau; Grit Herter-Sprie; Mohammad Ashab Uddin; Phil Jenkin; Abdulrahman Alsultan; Jochen Buechner; Jerry Stein; Agnes Kelemen; Andrea Jarisch; Jan Soerensen; Emilia Salzmann-Manrique; Martin Hutter; Richard Schäfer; Erhard Seifried; Thomas Klingebiel; Halvard Bonig; Selim Kuçi
Journal:  Bone Marrow Transplant       Date:  2018-01-29       Impact factor: 5.483
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.